Serological and biochemical studies using monoclonal antibodies have demonstrated that the Ly-15 cell membrane alloantigens are polymorphic sites on the lymphocyte function-associated antigen-i (LFA-1) molecule. Ly-15.2 and LFA-1 show identical tissue distributions, being present on all thymocytes, lymphocytes, and neutrophils, and flow cytofluorometric analysis indicated identical cell surface expression of these molecules. Identity of Antibodies have been used to define several immunologically important cell membrane structures on effector T lymphocytes in mice. These are (i) the T-cell receptor complex (i.e., antigen receptor and associated molecules including T3 in man and its putative equivalent in mouse) (1, 2), (ii) the Ly-2/3 molecule (3, 4), (iii) L3T4 (5), and (iv) lymphocyte function-associated antigen-1 (LFA-1) (6-8). The importance of these cell membrane molecules in T-cell function is seen from experiments in which specific antibodies binding to these molecules enhance or inhibit a particular function (1-8). The precise mechanism of enhancement or inhibition is not fully understood, but in the case of LFA-1, LFA-1 antibodies inhibit T-cell killing by preventing effector/target cell conjugation (7, 8) . Thus, it is believed that the LFA-1 molecule acts by assisting in the stable attachment of the cytotoxic T cell to its target. Biochemical studies of the murine LFA-1 molecule have shown it to be a heterodimer composed of a Mr 180,000 a chain non-covalently associated with a M, 95,000 , chain (9). Furthermore, other studies have demonstrated that the LFA-1 molecule is related to the Mac-1 molecule, which is present only on granulocytes and macrophages and is the C3bi receptor (10). Mac-1 is a heterodimer of Mr 177,000 a chain non-covalently bound to the same Mr 95,000 13 chain that is part of the LFA-1 complex; therefore, LFA-1 and Mac-1 comprise a family of immunologically important molecules (8, 11) .
phorese on two-dimensional NaDodSO4/PAGE. Furthermore, anti-Ly-15.2 and anti-LFA-1 antibodies coprecipitate the same molecule from thymocyte lysates, and peptide mapping studies show that the Ly-15.2 and LFA-1 a chains are identical, as are the .8 chains.
Antibodies have been used to define several immunologically important cell membrane structures on effector T lymphocytes in mice. These are (i) the T-cell receptor complex (i.e., antigen receptor and associated molecules including T3 in man and its putative equivalent in mouse) (1, 2) , (ii) the Ly-2/3 molecule (3, 4), (iii) L3T4 (5) , and (iv) lymphocyte function-associated antigen-1 (LFA-1) (6) (7) (8) . The importance of these cell membrane molecules in T-cell function is seen from experiments in which specific antibodies binding to these molecules enhance or inhibit a particular function (1) (2) (3) (4) (5) (6) (7) (8) . The precise mechanism of enhancement or inhibition is not fully understood, but in the case of LFA-1, LFA-1 antibodies inhibit T-cell killing by preventing effector/target cell conjugation (7, 8) . Thus, it is believed that the LFA-1 molecule acts by assisting in the stable attachment of the cytotoxic T cell to its target. Biochemical studies of the murine LFA-1 molecule have shown it to be a heterodimer composed of a Mr 180,000 a chain non-covalently associated with a M, 95,000 , chain (9) . Furthermore, other studies have demonstrated that the LFA-1 molecule is related to the Mac-1 molecule, which is present only on granulocytes and macrophages and is the C3bi receptor (10) . Mac-1 is a heterodimer of Mr 177,000 a chain non-covalently bound to the same Mr 95,000 13 chain that is part of the LFA-1 complex; therefore, LFA-1 and Mac-1 comprise a family of immunologically important molecules (8, 11) .
Many genes encoding cell-membrane alloantigens have been described in the mouse and include the major histocompatibility complex, immunoglobulin genes, and the Ly loci. At present, there are 30 known Ly loci, which are defined by antibodies recognizing polymorphic forms of cell-membrane alloantigens (12, 13) The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Proc. NatL Acad Sci. USA 82 (I ' 5) ed erythrocytes and depleting rosetted cells on isopaque Ficoll gradient (20) . Calcium caseinate-induced neutrophils, induced by intraperitoneal injection of 0.4% calcium caseinate, were purified by density gradient centrifugation (21) . Immunochemical Analysis. C57BL/6 thymocytes were labeled with 1251 using lactoperoxidase and were solubilized in buffer containing Triton X-100 (17) . Immunoprecipitations were performed by reaction of lysates with antibodies (5 ,ul of ascites or 50 ,l of supernatant) and by precipitating the immune complexes with rabbit anti-mouse Ig conjugated to Sepharose 4B (Pharmacia). Two-dimensional gels (IEF, first dimension; 7.5% NaDodSO4/PAGE, second dimension) were run under reducing conditions as described (17) . Coprecipitation studies of Ly-15.2 and LFA-1 were carried out by adding to lysate samples (5 x 106 cell equivalents) a large excess of anti-immunoglobulin Sepharose 4B conjugate (Pharmacia 4B) to which an excess of specific monoclonal antibodies or normal mouse Ig had been bound. Three sequential immunodepletions were carried out for each monoclonal antibody. Peptide mapping studies on radioactive protein bands were performed by excising the appropriate band from NaDodSO4/polyacrylamide gel and placing the dried gel strips into loading chambers of a NaDodSO4/15% polyacrylamide gel. The strips were rehydrated in situ in digestion buffer containing 50 ,ug of S. aureus V8 protease per ml (Miles). Subsequent steps were performed as described by Cleveland et al. (22) .
RESULTS AND DISCUSSION Ly-15 Locus. This was originally described in the mouse as a polymorphic two-allele alloantigenic locus (14) . Further analyses have been undertaken in this study, and additional strains of mice have been tested using the monoclonal anti- H-i, -2,   -3, -7, -8, -15, -16, -1 7, -18, -19, -20, -21, -22, -23, -24, -25, -26,  -27, -28, -29, -30, -36, - (Fig. 1) . More than 90% of thymocytes expressed only low levels of Ly-15.2 and LFA-1, but the fluorescence profiles were identical with a discrete peak at channel 1.4 for both antibodies ( Fig. 1 A and C) . Similarly, most lymph node T cells expressed low levels of Ly-15.2 and LFA-1, and these profiles were also identical. It should also be noted that an additional population of cells expressed relatively higher amounts of both of these antigens (more than channel 2.2) (Fig. 1 B and D) . These cells constituted 16% of (Table 2) .
Immunochemical Analysis. One-dimensional NaDodSO4/ PAGE indicated that Ly-15.2 and LFA-1 had a similar twochain molecular structure (data not shown) and the possible identity of the Ly-15.2 and LFA-1 molecules was directly addressed by two-dimensional NaDodSO4/PAGE, peptide mapping, and coprecipitation.
(i) Two-dimensional gels. The LFA-1 and Ly-15.2 molecules show the same subunit structure, each being composed of a Mr 180,000 a chain and a Mr 94,000(3 chain (Fig. 2) . The Ly-15.2 a or 8 chains also had an identical pI when compared to the LFA-1 a and (3chains. Indeed, in an experiment in which Ly-15.2 and LFA-1 immunoprecipitates were mixed prior to electrophoresis, the patterns of the a and (3 chains were indistinguishable from Ly-15.2 or LFA-1 alone-i.e., both antisera precipitate molecules of the same size and charge.
(it) Peptide mapping studies. These studies confirmed that the Ly-15.2 and LFA-1 molecules are related. LFA-1 and Ly-15.2 a chains yielded identical partial cleavage peptides after limited proteolysis with S. aureus V8 protease (Fig. 3) . Similarly, no differences between the ( chains were seen in the peptide maps. It should be noted that the a and (3 chains were clearly different from each other, and from the Pgp-1 molecule [a major leukocyte glycoprotein (24)] included for control purposes.
(iii) Coprecipitation studies. The data from the two-dimensional gels and peptide maps were consistent with the possibility that the Ly-15.2 and LFA-1 molecules were closely related or identical structures. Thus, coprecipitation studies (Fig. 4A) , anti-Ly-15.2 or anti-LFA-1 antibodies (Fig. 4 B and C, respectively) . The appropriate a and chains were precipitated by anti-Ly-15.2 and anti-LFA-1 antibodies after preclearing with normal mouse Ig (Fig. 2) . It should also be noted that a trace of material of Mr 170,000 is also seen, and preliminary evidence indicates that this is the precursor of the Mr 180,000 LFA-1 a chain. In addition, a trace of an a chain breakdown product of Mr 116,000 may be observed. Preclearance of the Ly-15.2 antigen resulted in the removal of most but not all of both Ly-15.2 and LFA-1 molecules (Fig. 4B ). In the reciprocal experiment, removal of the LFA-1 antigen also resulted in the removal of Ly-15.2 molecules (Fig. 4C) (Fig. 4, lanes b) .
Thus, the epitopes detected by the anti-Ly-15.2 and LFA-1 antibodies are present on the same structure. However, the relationship between the Ly-15.2 and LFA-1 epitopes is not clear, but as anti-Ly-15.2 antibodies detect a polymorphic site, whereas the anti-LFA-1 antibody detects a monomorphic site (common to all strains of mice), it is likely that they recognize different epitopes. Indeed, preliminary experiments indicate that anti-LFA-1 antibodies do not block the binding of anti-Ly-15.2 antibodies and anti-Ly-15.2 antibodies do not inhibit T-cell killing (unpublished), demonstrating that the two sites are probably distinct.
As LFA-1 is a heterodimeric molecule, the Ly-15 alloantigens could represent polymorphism of either the a chain or the p chain, or they may arise as a combinatorial determinant by association of different allelic forms (not serologically defined) of the a and p chains. Indeed, polymorphisms of individual proteins in multimeric molecules are seen in H-2 (j3-2 microglobulin and H-2) (25, 26) , immunoglobulin (heavy and light chains) (27, 28) , and Ly-2/3 (29) . Combinatorial polymorphisms have also been described for H-2 (30), Qa-2 (31), and Ia (32) , but at present it is not clear whether the Ly-15.2 epitope is chain specific or combinatorial. Most anti-LFA-1 monoclonal antibodies detect epitopes present on the a chain and it will be important to determine the chain location of the Ly-15.2 epitope, as one major advantage of alloantibodies is their use in gene mapping studies. LFA-1 is one member of a family of related heterodimeric molecules that all share the same p chain. These include Mac-1 (C3bi receptor) in the mouse, and in humans, LFA-1 (33, 34), OKM1 (C3bi receptor that is also detected by the murine Mac-i antibody) (35) , and gp 150,95, the function of which is unknown (34, 35) . At present, the location of the genes coding for either a or p chains is unknown, but the use of antibodies directed against polymorphic determinants of these chains will assist gene mapping studies yielding information required to understand the genetic and structural relationships between LFA-1 and related molecules.
